Stage IVB Prostate Cancer AJCC v8 Terminated Phase 2 Trials for Abiraterone (DB05812)

IndicationStatusPhase
DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03649841Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate CancerTreatment
NCT03999515Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate CancerTreatment